Shanthi Pal

2.1k total citations
33 papers, 1.3k citations indexed

About

Shanthi Pal is a scholar working on Toxicology, Economics and Econometrics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Shanthi Pal has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Toxicology, 9 papers in Economics and Econometrics and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Shanthi Pal's work include Pharmacovigilance and Adverse Drug Reactions (15 papers), Pharmaceutical Economics and Policy (9 papers) and Neuroscience and Neuropharmacology Research (5 papers). Shanthi Pal is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (15 papers), Pharmaceutical Economics and Policy (9 papers) and Neuroscience and Neuropharmacology Research (5 papers). Shanthi Pal collaborates with scholars based in Switzerland, Sweden and United States. Shanthi Pal's co-authors include Sten Olsson, K.K. Pillai, Dennis Falzon, Chris Duncombe, Divya Vohora, Paul E. Gold, Michael E. Ragozzino, Mark R. Stefani, Alex Dodoo and Andy Stergachis and has published in prestigious journals such as The Lancet, Journal of Neuroscience and Brain Research.

In The Last Decade

Shanthi Pal

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shanthi Pal Switzerland 18 629 322 268 191 186 33 1.3k
Linda Härmark Netherlands 23 812 1.3× 297 0.9× 325 1.2× 286 1.5× 50 0.3× 59 1.4k
Nicola Montanaro Italy 27 223 0.4× 266 0.8× 138 0.5× 365 1.9× 440 2.4× 97 2.2k
Lise Aagaard Denmark 17 383 0.6× 154 0.5× 258 1.0× 158 0.8× 19 0.1× 41 1.0k
Isabelle Lacroix France 23 135 0.2× 35 0.1× 537 2.0× 162 0.8× 95 0.5× 119 2.2k
David M Coulter New Zealand 17 130 0.2× 72 0.2× 250 0.9× 108 0.6× 53 0.3× 42 1.1k
Emmanuelle Bondon‐Guitton France 17 178 0.3× 35 0.1× 122 0.5× 148 0.8× 28 0.2× 44 834
Élisabeth Polard France 19 44 0.1× 87 0.3× 107 0.4× 163 0.9× 37 0.2× 75 1.1k
Paul L. Doering United States 19 78 0.1× 66 0.2× 203 0.8× 99 0.5× 112 0.6× 57 1.1k
Nancy Chen United States 20 24 0.0× 130 0.4× 200 0.7× 319 1.7× 148 0.8× 61 2.0k
L. DiAnne Bradford United States 16 56 0.1× 44 0.1× 370 1.4× 309 1.6× 224 1.2× 24 2.2k

Countries citing papers authored by Shanthi Pal

Since Specialization
Citations

This map shows the geographic impact of Shanthi Pal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanthi Pal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanthi Pal more than expected).

Fields of papers citing papers by Shanthi Pal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanthi Pal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanthi Pal. The network helps show where Shanthi Pal may publish in the future.

Co-authorship network of co-authors of Shanthi Pal

This figure shows the co-authorship network connecting the top 25 collaborators of Shanthi Pal. A scholar is included among the top collaborators of Shanthi Pal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanthi Pal. Shanthi Pal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bucci, Lucie M., et al.. (2023). A social media intervention for communicating vaccine safety in low- and middle-income countries: protocol for a pilot study. Frontiers in Public Health. 11. 1248949–1248949. 1 indexed citations
3.
Blau, Erin F., et al.. (2023). Progress in Immunization Safety Monitoring — Worldwide, 2020–2022. MMWR Morbidity and Mortality Weekly Report. 72(49). 1321–1326. 5 indexed citations
4.
McDowell, Michelle, et al.. (2022). The Good Talk! A Serious Game to Boost People’s Competence to Have Open Conversations About COVID-19: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 12. e40753–e40753. 4 indexed citations
5.
Fukushima, Ayako, Noha Iessa, Madhava Ram Balakrishnan, & Shanthi Pal. (2022). Smartphone-based mobile applications for adverse drug reactions reporting: global status and country experience. BMC Medical Informatics and Decision Making. 22(1). 118–118. 20 indexed citations
6.
Iessa, Noha, Lilit Ghazaryan, José L. Castro, et al.. (2021). Smart Safety Surveillance (3S): Multi-Country Experience of Implementing the 3S Concepts and Principles. Drug Safety. 44(10). 1085–1098. 9 indexed citations
8.
Pal, Shanthi, Sten Olsson, & Elliot G. Brown. (2015). The Monitoring Medicines Project: A Multinational Pharmacovigilance and Public Health Project. Drug Safety. 38(4). 319–328. 27 indexed citations
10.
Beckmann, Jürgen, Ulrich Hagemann, Priya Bahri, et al.. (2014). Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum. Drug Safety. 37(10). 743–759. 34 indexed citations
11.
Falzon, Dennis, et al.. (2014). Pharmacovigilance and tuberculosis: applying the lessons of thioacetazone. Bulletin of the World Health Organization. 92(12). 918–919. 15 indexed citations
12.
Pal, Shanthi, Chris Duncombe, Dennis Falzon, & Sten Olsson. (2013). WHO Strategy for Collecting Safety Data in Public Health Programmes: Complementing Spontaneous Reporting Systems. Drug Safety. 36(2). 75–81. 172 indexed citations
13.
Hunsel, Florence van, Linda Härmark, Shanthi Pal, Sten Olsson, & Kees van Grootheest. (2011). Experiences with Adverse Drug Reaction Reporting by Patients. Drug Safety. 35(1). 45–60. 113 indexed citations
14.
Bakare, Nyasha, I. Ralph Edwards, Andy Stergachis, et al.. (2011). Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities. PLoS Medicine. 8(7). e1001054–e1001054. 16 indexed citations
15.
Olsson, Sten, Shanthi Pal, Andy Stergachis, & Mary Couper. (2010). Pharmacovigilance Activities in 55 Low- and Middle-Income Countries. Drug Safety. 33(8). 689–703. 128 indexed citations
16.
Olsson, Sten & Shanthi Pal. (2006). Drug bulletins: independent information for global use. The Lancet. 368(9539). 903–904. 4 indexed citations
17.
Vohora, Divya, Shanthi Pal, & K.K. Pillai. (2005). Modulation of spontaneous alternation performance of mice treated with thioperamide and tacrine in a cross maze task. Fundamental and Clinical Pharmacology. 19(5). 531–532. 18 indexed citations
18.
Vohora, Divya, Shanthi Pal, & K.K. Pillai. (2001). Histamine and selective H3-receptor ligands: a possible role in the mechanism and management of epilepsy. Pharmacology Biochemistry and Behavior. 68(4). 735–741. 49 indexed citations
19.
Vohora, Divya, Shanthi Pal, & K.K. Pillai. (2000). Thioperamide, a selective histamine H3 receptor antagonist, protects against PTZ-induced seizures in mice. Life Sciences. 66(22). PL297–PL301. 46 indexed citations
20.
Login, Ivan S., et al.. (1998). Muscimol increases acetylcholine release by directly stimulating adult striatal cholinergic interneurons. Brain Research. 779(1-2). 33–40. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026